Alpha Tau Medical Ltd. (NASDAQ:DRTSW – Get Free Report) was the target of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 9,443 shares, an increase of 96.6% from the June 30th total of 4,802 shares. Based on an average daily trading volume, of 54,956 shares, the short-interest ratio is currently 0.2 days.
Alpha Tau Medical Stock Performance
Shares of NASDAQ DRTSW opened at $2.29 on Thursday. Alpha Tau Medical has a 1 year low of $0.20 and a 1 year high of $4.28. The firm’s 50 day moving average price is $2.70 and its 200 day moving average price is $1.66.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.
The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.
Featured Stories
- Five stocks we like better than Alpha Tau Medical
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.
